Avricore Health closes $1.254M private placement
What's the deal? Avricore HealthDealroom has a profile for this one. Try Dealroom →, a Vancouver-based health company listed on the TSX Venture Exchange (TSXV: AVCR), has closed a $1.254M non-brokered private placement. The company issued 25,080,000 units at $0.05 per unit, with the deal closing on June 16, 2026.
The financing was first announced on May 20, 2026, and represents a post-IPO equity raise for the publicly traded firm.
What could go wrong? At $0.05 per unit, the low share price suggests Avricore is a micro-cap stock — a category that typically carries higher volatility and liquidity risk. A $1.25M raise is modest, and depending on the company's burn rate, it may not provide an extended runway.
Non-brokered placements also mean existing shareholders face dilution without the validation that comes from an institutional underwriter backing the deal.
The signal: Avricore Health's $1.25M raise at $0.05 per unit underscores the constrained fundraising environment facing early-stage public health companies on junior exchanges. Dealroom classifies Avricore as still at the early stage despite its TSXV listing, highlighting how micro-cap public markets increasingly resemble venture-style financing — with the added burden of public disclosure and dilution.
Read more: aktiencheck.de
